Anti IgE Treatment for Severe Allergic Asthma Treatment
A humanized monoclonal antibody against IgE, neutralizes free IgE and reduces IgE receptors on basophils and mast cells. It is given in the form of regular (usually every four weeks) subcutaneous injections. There are indications and contraindications for this treatment. Some information is given in the articles, presented below.
Please register as a new patient.
We use latest scientific achievements, diagnostic methods and treatments including Anti-IgE
Information about this medication can be obtained from manufactures’s website www.xolair.com
Articles on Anti IgE treatment in asthma and other allergic pathologies.
Clinical efficacy of Anti-IgE treatment in an elderly veteran population with severe asthma
Elderly patients with severe atopic asthma show a significant positive clinical response to Anti-IgE treatment
 |
Clinical efficacy of Anti-IgE treatment in an elderly veteran population …
Source: Allergy and Asthma Proceedings, Volume 32, Number 5, September |
N Engl J Med 2011; 364:2556-2558June 30, 2011
Anti-IgE for Asthma in Inner-City Children.
Correspondence
Department of Medicine, Creighton University, Omaha, NE, USA. tbcasale@creighton.edu
Article
JAMA. 2001 Dec 19;286(23):2956-67.
Effect of Anti-IgE treatment on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, McAlary M, Fowler-Taylor A, Racine A, Gupta N, Fick R, Della Cioppa G; Anti-IgE treatment Seasonal Allergic Rhinitis Trail Group.
Source
Department of Medicine, Creighton University, Omaha, NE, USA. tbcasale@creighton.edu
Abstract
Treat Respir Med. 2004;3(3):183-99.
Anti-IgE treatment: a review of its use in the management of allergic asthma.
Source
Adis International Inc., Yardley, Pennsylvania 19607, USA. demail@adis.com
Abstract
BioDrugs. 2004;18(6):415-8.
Spotlight on Anti-IgE treatment in allergic asthma.
Source
Adis International Limited, 770 Township Line Road, Yardley, PA 19047, USA.
Abstract
J Allergy Clin Immunol. 2011 May 31. [Epub ahead of print]
Efficacy and safety of Anti-IgE treatment in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P.Abstract